Pneumocystis jirovecipneumonia in relation to CD4+ lymphocyte count in patients with B-cell non-Hodgkin lymphoma treated with chemotherapy

Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma

(2010) Hiroo Katsuya et al.   LEUKEMIA & LYMPHOMA

A resurgence ofPneumocystisin aggressive lymphoma treated with R-CHOP-14: the price of a dose-dense regimen?

(2010) Tamar Tadmor et al.   LEUKEMIA & LYMPHOMA

High incidence ofPneumocystis jiroveciipneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone

(2010) Sarah Kamel et al.   LEUKEMIA & LYMPHOMA

Polymerase Chain Reaction for Diagnosing Pneumocystis Pneumonia in Non-HIV Immunocompromised Patients With Pulmonary Infiltrates

(2009) Élie Azoulay et al.   CHEST

Increased incidence of interstitial pneumonia by CHOP combined with rituximab

(2008) Daisuke Ennishi et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma

(2008) Xin Liu et al.   LEUKEMIA & LYMPHOMA